BIRC5 and cancer: Survivin belongs to the inhibitor of apoptosis (IAP) anti-apoptotic family of proteins and its aberrant expression is associated with increased tumour proliferation, progression, angiogenesis, resistance to therapy, and poor prognosis in several cancers [20,21,22,23].